A Double-Blind Placebo-Controlled Clinical Evaluation of Multistem for the Treatment of Ischemic Stroke
暂无分享,去创建一个
L. Wechsler | J. Switzer | D. Hess | R. Mays | A. Furlan | C. Sila | A. Furlan
[1] S. Ellis,et al. Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction: Phase I Clinical Study , 2012, Circulation research.
[2] P. Kaufmann,et al. Efficiency perspectives on adaptive designs in stroke clinical trials. , 2011, Stroke.
[3] M. Hermiston,et al. Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1–Mediated Inflammatory Response , 2011, Science Translational Medicine.
[4] K. Furie,et al. Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies , 2011, Stroke.
[5] D. Hess,et al. Cell therapy for ischaemic stroke , 2011, Cell proliferation.
[6] C. Verfaillie,et al. Multipotent adult progenitor cells. , 2011, Best practice & research. Clinical haematology.
[7] K. Horn,et al. Multipotent Adult Progenitor Cells Prevent Macrophage-Mediated Axonal Dieback and Promote Regrowth after Spinal Cord Injury , 2011, The Journal of Neuroscience.
[8] G. V. Bokkelen. Company profile: Athersys. , 2011 .
[9] Gil Van Bokkelen. Company profile: Athersys. , 2011, Regenerative medicine.
[10] Shinil K. Shah,et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes , 2010, Experimental Neurology.
[11] D. Hess,et al. Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke , 2010 .
[12] Jeffrey L Saver,et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. , 2009, Stroke.
[13] P. Delafontaine,et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.
[14] B. Reynolds. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating Stroke , 2009, Stroke.
[15] G. Moneta,et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke , 2009 .
[16] P. Streeter,et al. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. , 2009, Cellular immunology.
[17] H. Neumann,et al. Hematopoietic Stem Cells Reduce Postischemic Inflammation and Ameliorate Ischemic Brain Injury , 2008, Stroke.
[18] A. Luttun,et al. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. , 2008, The Journal of clinical investigation.
[19] R. Mays,et al. Therapeutic pathways of adult stem cell repair. , 2008, Critical reviews in oncology/hematology.
[20] R. Mays,et al. Development of adult pluripotent stem cell therapies for ischemic injury and disease , 2007, Expert opinion on biological therapy.
[21] Yi Li,et al. Therapeutic Benefit of Bone Marrow Stromal Cells Administered 1 Month after Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Z. Popović,et al. Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. , 2007, Cytotherapy.
[23] Catherine M. Verfaillie,et al. Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.
[24] P. Hurn,et al. Splenic Atrophy in Experimental Stroke Is Accompanied by Increased Regulatory T Cells and Circulating Macrophages1 , 2006, The Journal of Immunology.
[25] P. Bickford,et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function , 2006, Experimental Neurology.
[26] P. Hurn,et al. Experimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] D. Hess,et al. Behavioral and Histological Characterization of Intrahippocampal Grafts of Human Bone Marrow-Derived Multipotent Progenitor Cells in Neonatal Rats with Hypoxic-Ischemic Injury , 2006, Cell transplantation.
[28] D. Hess,et al. Transplantation of Cryopreserved Human Bone Marrowderived Multipotent Adult Progenitor Cells for Neonatal Hypoxie- Ischemic Injury: Targeting the Hippocampus , 2006, Reviews in the neurosciences.
[29] J. De Keyser. Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.
[30] D. Mevorach,et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. , 2005, Blood.
[31] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[32] D. Henderson,et al. Neuroectodermal differentiation from mouse multipotent adult progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Verfaillie,et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. , 2002, Experimental hematology.
[34] C. Verfaillie,et al. Human Bone Marrow Stem Cells Exhibit Neural Phenotypes and Ameliorate Neurological Deficits after Grafting into the Ischemic Brain of Rats , 2002, Experimental Neurology.
[35] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .